040-000-290 Piperaquine, CAS 4085-31-8
Get A Quote
| Synonyms | Piperaquine Phosphate, Sotalol Hydrochloride, Piperaqu, Piperaquinoline |
| Keywords | Malaria, artemisinin, Artemisia Annua Extract, COVID-19, SARS-CoV-2 |
| Related products | Artemisinin, hydroxychloroquine |
Stanford Chemicals Company is a Piperaquine supplier in USA. We offer the small Piperaquine phosphate sample and bulk powders.
Description
Description
Piperaquine Specifications
| Product Name | Piperaquinoline |
| CAS Registry Number | 4085-31-8 |
| Molecular Formula | C29H32Cl2N6 |
| Molecular Weight | 535.51 g/mol |
| Purity | >99.0 % |
| Appearance | White powder |
| Shelf life | 2 years |
| Functions | highly active against chloroquine-resistant Plasmodium falciparum and Plasmodium vivax |
Piperaquine Description
Piperaquine is an antiparasitic drug used in combination with dihydroartemisinin to treat malaria. It is a bis-quinoline compound that inhibits the vitro growth of P. falciparum isolates from malaria-infected patients with IC50s ranging from 11.8-217.3 nM. Piperaquine was developed under the Chinese National Malaria Elimination Programme in the 1960s and was adopted throughout China as a replacement for the structurally similar antimalarial drug chloroquine.
Piperazine phosphate has also recently become a potential drug against COVID-19.
Piperaquine
Piperaquine Applications
- Used as a partner drug for artemisinin combination therapy
- Potential drug against SARS-COV-2
Reference:
- Akoachere, M., Buchholz, K., Fischer, E., et al. In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob. Agents Chemother. 49(11), 4592-4597 (2005).
- Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF (2005). “Piperaquine: a resurgent antimalarial drug”. Drugs. 65 (1): 75–87.
- Haldar K, Bhattacharjee S, Safeukui I (2018). “Drug resistance in Plasmodium”. Nature Reviews Microbiology. 16: 156–170.
